The stock of Haoxi Health Technology Ltd. (HAO) has seen a -84.74% decrease in the past week, with a -86.16% drop in the past month, and a -89.28% decrease in the past quarter. The volatility ratio for the week is 38.29%, and the volatility levels for the past 30 days are at 22.58% for HAO. The simple moving average for the past 20 days is -83.46% for HAO’s stock, with a -89.76% simple moving average for the past 200 days.
Is It Worth Investing in Haoxi Health Technology Ltd. (NASDAQ: HAO) Right Now?
The public float for HAO is 7.76M, and currently, short sellers hold a 5.85% ratio of that floaft. The average trading volume of HAO on September 23, 2024 was 773.83K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HAO) stock’s latest price update
Haoxi Health Technology Ltd. (NASDAQ: HAO) has experienced a decline in its stock price by -27.50 compared to its previous closing price of 0.80. However, the company has seen a fall of -84.74% in its stock price over the last five trading days. globenewswire.com reported 2024-09-20 that BEIJING, Sept. 20, 2024 (GLOBE NEWSWIRE) — Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that it closed its previously announced underwritten follow-on offering of 4,000,000 units (each a “Unit,” and collectively, the “Units”) at a public offering price of $3.00 per Unit (the “Offering”). Each Unit consists of (i) one share of Class A Ordinary Share, par value $0.0001 per share (the “Class A Ordinary Share”) (or one pre-funded warrant to purchase one Class A Ordinary Share (the “Pre-Funded Warrant”)), (ii) one Series A warrant to purchase one Class A Ordinary Share (the “Series A Warrant”) initially, but five Class A Ordinary Shares on and after the Series B Exercise Date, and (iii) one Series B warrant to purchase four of Class A Ordinary Shares on and after the sixteenth (16th) calendar day (the “Series B Exercise Date”) following the closing of the Offering (the “Series B Warrant”, together with the Series A Warrant, the “Warrants”). The Units have no stand-alone rights and therefore are not certificated or issued as stand-alone securities. The Class A Ordinary Shares and related Warrants are issued separately in the Offering. The Company received aggregate gross proceeds of $12,000,000 from the Offering, before deducting underwriting discounts and other offering expenses, excluding the exercise of any Warrants.
HAO Trading at -85.00% from the 50-Day Moving Average
After a stumble in the market that brought HAO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.53% of loss for the given period.
Volatility was left at 22.58%, however, over the last 30 days, the volatility rate increased by 38.29%, as shares sank -84.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -91.12% lower at present.
During the last 5 trading sessions, HAO fell by -84.74%, in comparison to the 20-day moving average, which settled at $3.3470. In addition, Haoxi Health Technology Ltd. saw -89.02% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for HAO
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 0.06 for the gross margin
The net margin for Haoxi Health Technology Ltd. stands at 0.03. The total capital return value is set at 0.94.
Based on Haoxi Health Technology Ltd. (HAO), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at -0.56. The debt to equity ratio resting at 0.64. The interest coverage ratio of the stock is 114.99.
Currently, EBITDA for the company is 1.2 million with net debt to EBITDA at -0.0. When we switch over and look at the enterprise to sales, we see a ratio of 0.34. The receivables turnover for the company is 248.62for trailing twelve months and the total asset turnover is 8.8. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.31.
Conclusion
In a nutshell, Haoxi Health Technology Ltd. (HAO) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
